期刊文献+

酶联免疫斑点技术在肿瘤研究中的应用 被引量:2

Application of enzyme-linked immunospot assay in tumor research
下载PDF
导出
摘要 酶联免疫斑点技术(enzyme-linked immunospot assay,ELISPOT)广泛应用在肿瘤疫苗开发、疗效评价和肿瘤病因研究方面,本文就ELISPOT技术的历史、原理、一般步骤、在肿瘤研究中的应用及优缺点做一综述。 The enzyme-linked immunospot assay(ELISPOT) is widespread used in the fields of tumor vaccine exploitation,therapeutic effect evaluation,and tumor etiopathogenisis research.This review introduces the history,principle,and general procedure of ELISPOT,as well as the advantage and disadvantage of ELISPOT application in tumor research.
出处 《免疫学杂志》 CAS CSCD 北大核心 2006年第z1期101-104,共4页 Immunological Journal
关键词 酶联免疫斑点技术 抗原 肿瘤 Enzyme-linked immunospot Antigen Tumor
  • 相关文献

参考文献19

  • 1[1]Helms T,Boehm BO,Asaad RJ,et al.Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients[J].J Immunol,2000,164(7):3 723-3 732.
  • 2[2]Czerkinsky C,Nilsson LA,Nygren H,et al.A solid-phase enzyme-linked immunospot(ELISPOT) assay for enumeration of specific antibody-secreting cells[J].J Immunol Methods,1983,65 (1/2):109-121.
  • 3[3]Okamoto Y,Nishida M.Dual-color ELISPOT assay for analyzing cytokine balance[ J ].Methods Mol Biol,2005,302:263-272.
  • 4[4]Doan T,Herd K,Ranshaw I,et al.A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour[ J ].Cancer Immunol Immunother,2005,54 (2):157-171.
  • 5[5]Miller AM,Ozenci V,Kiessling R,et al.Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer[J].J Immunother,2005,28(4):389-395.
  • 6[6]Tang J,Flomenberg P,Harshyne L,et al.Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells[ J].Clin Cancer Res,2005,11(14):5 292-5 299.
  • 7[7]Kaufman HL,Deraffele G,Mitcham J,et al.Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma[J].J Clin Invest,2005,115(7):1 903-1 912.
  • 8[8]Kyte JA,Kvalheim G,Aamdal S,et al.Preclinical fullscale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination[J].Cancer Gene Ther,2005,12(6):579-592.
  • 9[9]Meyer RG,Britten CM,Siepmann U,et al.A phase Ⅰ vaccination study with tyrosinase in patients with stage Ⅱ melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)[ J ].Cancer Immunol Immunother,2005,54(5):453-467.
  • 10[10]Chi KH,Liu SJ,Li CP,et al.Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma[ J ].J Immunother,2005,28(2):129-135.

同被引文献16

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部